Gayatri BioOrganics Limited (BOM:524564)
India
· Delayed Price · Currency is INR 6.92
+0.07 (1.02%)
At close: May 15, 2025
Gayatri BioOrganics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | - | 0.31 | 0.25 | 0.33 | 4.38 | 9.56 | Upgrade
|
| Cash & Short-Term Investments | 0.31 | 0.31 | 0.25 | 0.33 | 4.38 | 9.56 | Upgrade
|
| Cash Growth | - | 24.00% | -24.01% | -92.48% | -54.23% | 315.65% | Upgrade
|
| Accounts Receivable | - | 2.54 | 2.54 | 4.85 | 4.85 | 4.85 | Upgrade
|
| Other Receivables | - | - | - | 2.44 | 2.44 | 2.44 | Upgrade
|
| Receivables | - | 2.54 | 2.54 | 7.28 | 7.28 | 7.28 | Upgrade
|
| Prepaid Expenses | - | 0 | 0 | 0.01 | 0.01 | - | Upgrade
|
| Other Current Assets | - | 12.92 | 13.37 | 13.81 | 13.35 | 13.19 | Upgrade
|
| Total Current Assets | - | 15.77 | 16.16 | 21.43 | 25.02 | 30.03 | Upgrade
|
| Long-Term Investments | - | - | - | 0.02 | 0.02 | 0.02 | Upgrade
|
| Other Long-Term Assets | - | 0 | - | 0.91 | 0.91 | 0.89 | Upgrade
|
| Total Assets | - | 15.77 | 16.16 | 22.36 | 25.94 | 30.94 | Upgrade
|
| Accounts Payable | - | 1.77 | 2.13 | 4.69 | 4.42 | 4.46 | Upgrade
|
| Accrued Expenses | - | 2.07 | 2.27 | 1.36 | 0.25 | 0.24 | Upgrade
|
| Short-Term Debt | - | 334.04 | 334.04 | 334.04 | 334.04 | 334.04 | Upgrade
|
| Other Current Liabilities | - | 0 | - | - | 0 | - | Upgrade
|
| Total Current Liabilities | - | 337.87 | 338.44 | 340.09 | 338.71 | 338.74 | Upgrade
|
| Long-Term Debt | - | 29.57 | 22.57 | 17.02 | 17.02 | 17.02 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | -0 | - | Upgrade
|
| Total Liabilities | - | 367.44 | 361.01 | 357.11 | 355.72 | 355.75 | Upgrade
|
| Common Stock | - | 787.88 | 787.88 | 787.88 | 787.88 | 787.88 | Upgrade
|
| Additional Paid-In Capital | - | 29.93 | 29.93 | 29.93 | 29.93 | 29.93 | Upgrade
|
| Retained Earnings | - | -1,170 | -1,164 | -1,154 | -1,149 | -1,144 | Upgrade
|
| Comprehensive Income & Other | - | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Total Common Equity | -355.58 | -351.67 | -344.86 | -334.75 | -329.79 | -324.81 | Upgrade
|
| Shareholders' Equity | -355.58 | -351.67 | -344.86 | -334.75 | -329.79 | -324.81 | Upgrade
|
| Total Liabilities & Equity | - | 15.77 | 16.16 | 22.36 | 25.94 | 30.94 | Upgrade
|
| Total Debt | 367.61 | 363.61 | 356.61 | 351.05 | 351.05 | 351.05 | Upgrade
|
| Net Cash (Debt) | -367.3 | -363.3 | -356.36 | -350.72 | -346.68 | -341.49 | Upgrade
|
| Net Cash Per Share | -4.51 | -4.61 | -4.52 | -4.45 | -4.40 | -4.33 | Upgrade
|
| Filing Date Shares Outstanding | 80.3 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | Upgrade
|
| Total Common Shares Outstanding | 80.3 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | Upgrade
|
| Working Capital | - | -322.1 | -322.28 | -318.66 | -313.69 | -308.7 | Upgrade
|
| Book Value Per Share | -3.99 | -4.46 | -4.38 | -4.25 | -4.19 | -4.12 | Upgrade
|
| Tangible Book Value | -355.58 | -351.67 | -344.86 | -334.75 | -329.79 | -324.81 | Upgrade
|
| Tangible Book Value Per Share | -3.99 | -4.46 | -4.38 | -4.25 | -4.19 | -4.12 | Upgrade
|
Updated Jan 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.